Pancreatic cancer mRNA vaccine shows lasting results in an early trial​Pancreatic cancer mRNA vaccine shows lasting results in an early trial 

 Nearly all of the patients who responded to the a personalized mRNA pancreatic vaccine are still alive six years later.  ​​Nearly all of the patients who responded to the a personalized mRNA pancreatic vaccine are still alive six years later.